ClinicalTrials.Veeva

Menu

PCOT for Outpatients With Acute Respiratory Tract Infection at Risk of Severe Disease in Primary Healthcare

C

Capital Medical University

Status

Not yet enrolling

Conditions

Acute Respiratory Tract Infection

Treatments

Diagnostic Test: point-of-care multiplex PCR test

Study type

Interventional

Funder types

Other

Identifiers

NCT07159230
2024-KY-434

Details and patient eligibility

About

This study aims to evaluate the clinical value of point-of-care multiplex PCR testing (POCT) in guiding early diagnosis and target treatment for acute respiratory infections in primary healthcare settings.

Full description

Advanced age, comorbidities, and immunosuppression are high-risk factors of severe disease in acute respiratory infections. In China, the exacerbation of population aging and increasing number of individuals with chronic comorbidities have aggravated the severity of the issue and posed a serious challenge to public health. However, insufficient pathogen diagnostic capabilities in primary healthcare prevents patients at high risk of severe disease from receiving timely and targeted treatments, potentially leading to delays in clinical management, adverse prognoses and increased economic burdens. This study aims to evaluate the clinical value of point-of-care multiplex PCR testing (POCT) in guiding early diagnosis and target treatment for acute respiratory infections in primary healthcare settings.

Enrollment

16,868 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Onset time<=7 days;
  2. First visit;
  3. Age>=18 years old;
  4. Patients with acute upper respiratory tract infection with severe high-risk factors, or patients with acute lower respiratory tract infection;
  5. The condition is allowed to be treated in an outpatient clinic;
  6. Signed informed consent.

Exclusion criteria

  1. The doctor judges that the disease is serious and requires hospitalization;
  2. New unclear consciousness;
  3. Respiratory rate>=30 beats/min;
  4. Hypoxemia or respiratory failure;
  5. Heart rate> 125 beats/min;
  6. Systolic blood pressure < 90 or diastolic blood pressure < 60 mmHg;
  7. Known active tuberculosis;
  8. Pregnant and lactating women;
  9. Have participated in this study within 90 days;

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

16,868 participants in 2 patient groups

intervention group
Experimental group
Description:
community health care center in intervention group were provided with point-of-care multiplex PCR test (POCT) plus routine test. POCT testing was recommended for all enrolled patients presenting with acute respiratory infections who meet the predefined inclusion criteria. The therapeutic interventions were determined by health-care workers on the basis of POCT result, clinical assessment and guideline.
Treatment:
Diagnostic Test: point-of-care multiplex PCR test
control group
No Intervention group
Description:
patients in the control group will take the routine tests and receive anti-infective treatment according to clinical assessment and guideline.

Trial contacts and locations

1

Loading...

Central trial contact

Fei Zhou, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems